V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158185 | 20060529 | 1.81 | 95.7 | Palliative (P) | 2019-10-08 | 2019-10-12 | ECX | N | N | ECX | 100624794 |
| 20158186 | 20060530 | 1.5 | 74.2 | Adjuvant (A) | 2016-08-19 | 2016-08-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101326410 |
| 20158187 | 20060531 | 1.75 | 77.6 | Palliative (P) | 2018-10-13 | 2018-10-30 | ECX | N | N | ECX | 101805766 |
| 20158188 | 20060532 | 1.6 | 74 | Palliative (P) | 2018-12-20 | 2018-12-26 | ECX | 02 | null | ECX | 100354770 |
| 20158190 | 20060533 | 1.7 | 72 | Neo-adjuvant (N) | 2016-02-25 | 2016-02-25 | ECX | 02 | null | ECX | 100464199 |
| 20158191 | 20060534 | 1.78 | 77.2 | Disease modification (D) | null | 2017-04-27 | ECX | null | N | ECX | 101019978 |
| 20158192 | 20060535 | 1.69 | 94.8 | Adjuvant (A) | 2019-02-11 | 2019-02-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101727915 |
| 20158194 | 20060536 | 1.5 | 88.9 | Curative (C) | 2018-05-08 | 2018-05-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100805800 |
| 20158195 | 20060537 | 1.8 | 72 | Adjuvant (A) | 2019-09-16 | 2019-09-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101839279 |
| 20158200 | 20060538 | 1.74 | 82 | Palliative (P) | 2019-09-15 | 2019-09-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100787286 |
| 20158201 | 20060539 | 1.57 | 57.5 | Adjuvant (A) | 2019-10-15 | 2019-10-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100585544 |
| 20158202 | 20060540 | 1.78 | 65.3 | Neo-adjuvant (N) | 2018-05-10 | 2018-05-17 | ECX | N | null | ECX | 100865810 |
| 20158203 | 20060541 | 1.64 | 58.4 | Neo-adjuvant (N) | null | 2018-01-05 | CAPECITABINE + GEMCITABINE | null | N | ECX | 100626222 |
| 20158207 | 20060542 | 1.81 | 57.4 | Neo-adjuvant (N) | 2018-02-25 | 2018-03-10 | ECX | N | N | ECX | 101540234 |
| 20158209 | 20060543 | 1.79 | 73.1 | Adjuvant (A) | 2017-12-04 | 2018-01-04 | ECX | N | null | ECX | 100411558 |
| 20158211 | 20060544 | 1.76 | 87 | Neo-adjuvant (N) | 2016-07-14 | 2016-07-21 | Gemcitabine + Capecitabine | N | N | ECX | 100770822 |
| 20158212 | 20060545 | 1.71 | 67.2 | Curative (C) | 2018-06-13 | 2018-06-27 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101047919 |
| 20158213 | 20060546 | 1.7 | 96.9 | Neo-adjuvant (N) | 2019-04-04 | 2019-04-04 | ECX | 02 | N | ECX | 101143983 |
| 20158214 | 20060547 | 1.7 | 65.3 | Neo-adjuvant (N) | 2018-11-01 | 2018-11-11 | ECX | 02 | N | ECX | 100984729 |
| 20158215 | 20060548 | 1.8 | 88.9 | Neo-adjuvant (N) | 2018-09-14 | 2018-09-29 | ECX | N | N | ECX | 101488218 |
| 20158217 | 20060549 | 1.7 | 78.5 | Palliative (P) | 2016-07-01 | 2016-07-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100359649 |
| 20158218 | 20060550 | 1.72 | 81.6 | Curative (C) | 2017-02-10 | 2017-03-15 | Gemcitabine + Capecitabine | N | N | ECX | 101308439 |
| 20158219 | 20060551 | 1.68 | 85.7 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-19 | ECX | 2 | N | ECX | 101494667 |
| 20158223 | 20060552 | 1.69 | 60.6 | Palliative (P) | 2016-06-14 | 2016-06-20 | ECX | N | N | ECX | 101502978 |
| 20158225 | 20060553 | 1.8 | 98.8 | Palliative (P) | 2018-03-27 | 2018-04-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100688515 |
| 20158226 | 20060554 | null | 82.85 | Palliative (P) | 2019-05-18 | 2019-06-03 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100618375 |
| 20158229 | 20060555 | 1.73 | 60 | Palliative (P) | 2019-02-22 | 2019-03-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100964791 |
| 20158231 | 20060556 | 1.68 | 81.1 | Palliative (P) | 2018-06-29 | 2018-06-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100786795 |
| 20158235 | 20060557 | 1.66 | 55.6 | Palliative (P) | 2016-11-13 | 2016-12-02 | ECX | 2 | N | ECX | 100048801 |
| 20158238 | 20060558 | 1.68 | 92.1 | Neo-adjuvant (N) | 2017-07-28 | 2017-08-02 | ECX | 02 | N | ECX | 101387273 |
| 20158239 | 20060559 | 1.6 | 59.2 | Palliative (P) | 2018-01-12 | 2018-01-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100350446 |
| 20158240 | 20060560 | 1.66 | 54.3 | null | null | 2019-08-10 | ECX | N | N | ECX | 101475068 |
| 20158243 | 20060561 | 1.71 | 66.7 | Curative (C) | null | 2018-05-25 | ECX | null | N | ECX | 101317681 |
| 20158244 | 20060562 | 1.58 | 51.8 | Palliative (P) | 2017-07-03 | 2017-07-27 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101277589 |
| 20158245 | 20060563 | 1.6 | 63 | Palliative (P) | 2019-12-07 | 2019-12-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100126671 |
| 20158246 | 20060564 | 1.67 | 87.1 | Neo-adjuvant (N) | 2016-06-28 | 2016-06-29 | ECX | 02 | N | ECX | 100576045 |
| 20158247 | 20060565 | 1.78 | 87.2 | Adjuvant (A) | 2017-12-18 | 2017-12-18 | ECX | 02 | N | ECX | 100216169 |
| 20158248 | 20060566 | 1.72 | 77 | Neo-adjuvant (N) | 2016-12-10 | 2016-12-10 | ECX | 02 | N | ECX | 100719742 |
| 20158251 | 20060567 | 1.73 | 75.6 | Palliative (P) | 2018-06-20 | 2018-07-01 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101789356 |
| 20158252 | 20060568 | 1.63 | 56.8 | Adjuvant (A) | 2019-12-28 | 2020-01-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101858879 |
| 20158253 | 20060569 | 1.72 | 75 | null | 2017-10-10 | 2017-10-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100928747 |
| 20158254 | 20060570 | 1.72 | 39.6 | Palliative (P) | 2017-08-23 | 2017-09-11 | ECX | N | null | ECX | 100597123 |
| 20158255 | 20060571 | 1.86 | 62.8 | Neo-adjuvant (N) | 2019-05-20 | 2019-05-28 | ECX | N | N | ECX | 101717815 |
| 20158256 | 20060572 | 1.67 | 76 | Palliative (P) | 2020-01-29 | 2020-02-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100152684 |
| 20158259 | 20060573 | 1.84 | 60.1 | Neo-adjuvant (N) | 2016-09-04 | 2016-09-04 | ECX | N | N | ECX | 100785988 |
| 20158260 | 20060574 | 1.8 | 92 | Adjuvant (A) | 2018-03-29 | 2018-04-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101465035 |
| 20158261 | 20060575 | 1.65 | 79.4 | Adjuvant (A) | 2019-03-20 | 2019-03-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101174659 |
| 20158263 | 20060576 | 1.54 | 56.8 | Curative (C) | 2019-08-16 | 2019-09-02 | ECX | N | N | ECX | 101632027 |
| 20158264 | 20060577 | 1.77 | 62 | Palliative (P) | 2018-09-02 | 2018-09-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101804998 |
| 20158270 | 20060578 | 1.7 | 62 | Curative (C) | 2018-02-16 | 2018-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101816809 |